Results 111 to 120 of about 21,756 (223)

Diagnostic Approach to Left Ventricular Hypertrophy: A Review. [PDF]

US Cardiol
Banthiya S, Agrawal A, Rai D, Chowdhury M, Pan S, Naidu SS.   +5 more
europepmc   +1 more source

Beyond Traditional Screening: The Future of Heart Failure Detection With Biomarkers and AI

iNew Medicine, EarlyView.
Advancing HF Screening: Integrating Technology and Risk Factors Across Eras. This diagram provides a comprehensive review of the historical developments and projected trends of heart failure (HF) screening methodologies, with the prevalent risk factors for HF depicted at the base.
Xiaofeng Fang, Yinbo Xu, Yiting Zhao, Liuyi Li, Zhengyi Cheng, Zhongqi Zhang, Yuhang Luo, Qiaoling Liu, Chen Gong, Shichun Shen   +9 more
wiley   +1 more source

Thoracoscopically assisted resection of left ventricular myxoma: a case report. [PDF]

Front Cardiovasc Med
Zhang Y, Xue F, Qin M, Li J, Ma Y, Wang L, Guo Z.   +6 more
europepmc   +1 more source

Familial Primary Pulmonary Hypertension Locus Mapped to Chromosome 2q31-q32

Chest, 1998
J H, Morse, A C, Jones, R J, Barst, S E, Hodge, K C, Wilhelmsen, T G, Nygaard   +5 more
openaire   +2 more sources

Metrnl: A Novel Therapeutic Target in Atherosclerosis

iNew Medicine, EarlyView.
ABSTRACT Atherosclerosis is a chronic inflammatory vascular disease and the main pathological basis of cardiovascular and cerebrovascular events. Exploration of endogenous protective factors in the disease is beneficial for the establishment of new therapeutic strategies.
Pin Wang, Dao‐Xin Wang, Chao‐Yu Miao
wiley   +1 more source

Vascular compliance phenotyping in pulmonary arterial hypertension (a PVDOMICS study). [PDF]

JHLT Open
Wilson TG, Wilson TG, Oppegard L, Pi H, Houston BA, Tang WHW, Horn EM, Mukherjee M, Leary PJ, Robinson JC.   +9 more
europepmc   +1 more source

3 cases of familial primary pulmonary hypertension

Shinzo, 1989
Iga, Kanji, Tomii, Keisuke, Gen, Hiromitu, Tamamura, Toshitake, Matumura, Tadashi, Tomonaga, Go, Hori, Kenjiro   +6 more
openaire   +1 more source

S100A9 promotes pulmonary arterial hypertension by regulating mitochondria–endoplasmic reticulum interaction‐mediated inflammatory injury of endothelial cells

Interdisciplinary Medicine, EarlyView.
Macrophage‐derived S100 calcium‐binding protein A9 (S100A9) promotes the pathological progression of pulmonary arterial hypertension (PAH). S100A9 upregulates the interaction between signal‐transducing adaptor protein 2 and leucine‐rich repeat kinase 2, thereby regulating mitochondria–endoplasmic reticulum (ER) contact.
Chen Gong, Long Chen, Yiting Zhao, Xiaohe Wang, Qiang Yuan, Xiaofeng Fang, Liuyi Li, Yinbo Xu, Shumei Jiang, Guangwen Xu, Ke Meng, Delong Wang, Kangli Cao, Jianlong Sheng, Liling Guo, Shichun Shen   +15 more
wiley   +1 more source

The New Era of Pulmonary Hypertension: The Dawn of Disease Modification & Therapeutic Modalities. [PDF]

J Cardiovasc Dev Dis
Ramazani N, Barnes L, Wong A, Sharma D, Singh A, Lei K.   +5 more
europepmc   +1 more source

Compressed Sensing‐Accelerated 3.0 T Noncontrast‐Enhanced CMRA: Diagnostic Efficacy for Coronary Artery Stenosis

iRADIOLOGY, EarlyView.
This bar chart illustrates the diagnostic performance of coronary magnetic resonance angiography (CMRA) for detecting ≥ 50.00% coronary artery stenosis at the segment, vessel, and patient levels, including sensitivity, specificity, positive predictive value, negative predictive value, and accuracy.
Zhengfu Wang, Yue Zhu, Yi Yin, Zewang Li, Mingming Huang, Bo Gao   +5 more
wiley   +1 more source